Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)
Clinical trial NCT00796250 · TERMINATED
Trial details
- NCT number
- NCT00796250
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2005-01-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.